This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03426/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03426/identifier/pubchem-compound/
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03426/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03426/identifier/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03426
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n4:DB03426 n5:DB03426
dcterms:title
Digalactosyl Diacyl Glycerol (Dgdg)
adms:identifier
n9:DGD n10:46936671 n11:DB03426 n12:46504754
n6:IUPAC-Name
n7:271B4718-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B471E-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B471D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B471A-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B471B-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B471C-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4716-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4717-363D-11E5-9242-09173F13E4C5 n7:271B4714-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4715-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4724-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4725-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B471F-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4720-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4722-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4721-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4723-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B472A-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B472C-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B472D-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4729-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4728-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B472B-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4719-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4726-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4727-363D-11E5-9242-09173F13E4C5